The cancer-immunity cycle: Indication, genotype, and immunotype

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• The cancer-immunity cycle is a key framework for understanding anti-cancer immune responses.
• The cycle involves iterative steps of tumor cell killing, antigen presentation, and T-cell stimulation.
• Dysfunction at any stage can impair the immune system's ability to control tumor growth.

Purpose of the Study:

• To update the cancer-immunity cycle based on scientific advancements over the past decade.
• To integrate new understandings of immune checkpoint inhibition and dendritic cell function.
• To incorporate the role of the tumor microenvironment and tumor immunotype in anti-cancer immunity.

Main Methods:

• Review and synthesis of recent research in cancer immunology and immunotherapy.
• Conceptual framework update based on emerging evidence.
• Analysis of the impact of new findings on therapeutic strategies.

Main Results:

• The updated cycle reflects evolved understanding of immune checkpoint inhibitors.
• Dendritic cells' role in sustaining anti-tumor immunity is more clearly defined.
• The tumor microenvironment is recognized for both facilitating and suppressing anti-cancer responses.
• The concept of tumor immunotype is introduced as a critical factor.

Conclusions:

• The updated cancer-immunity cycle provides a more comprehensive view of anti-cancer immune responses.
• New insights offer novel targets for cancer research and therapeutic interventions.
• Understanding the tumor immunotype is crucial for developing effective cancer immunotherapies.